Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Outcomes of persistently active neovascular age-related macular degeneration treated with VEGF inhibitors: observational study data.
Barthelmes D, Walton R, Campain AE, Simpson JM, Arnold JJ, McAllister IL, Guymer RH, Hunyor AP, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Br J Ophthalmol. 2015 Mar;99(3):359-64. doi: 10.1136/bjophthalmol-2014-305514. Epub 2014 Sep 23. Br J Ophthalmol. 2015. PMID: 25249615 Free article.
Intravitreal therapy in bilateral neovascular age-related macular degeneration.
Barthelmes D, Walton RJ, Arnold JJ, McAllister IL, Simpson JM, Campain A, Hunyor AP, Guymer R, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: campain a. Ophthalmology. 2014 Oct;121(10):2073-4. doi: 10.1016/j.ophtha.2014.05.007. Epub 2014 Jun 14. Ophthalmology. 2014. PMID: 24939512 Free article. No abstract available.
Time to initial clinician-reported inactivation of neovascular age-related macular degeneration treated primarily with ranibizumab.
Gillies MC, Campain A, Walton R, Simpson JM, Arnold JJ, Guymer RH, McAllister IL, Hunyor AP, Essex RW, Morlet N, Barthelmes D; Fight Retinal Blindness Study Group. Gillies MC, et al. Among authors: campain a. Ophthalmology. 2015 Mar;122(3):589-594.e1. doi: 10.1016/j.ophtha.2014.10.001. Epub 2014 Nov 6. Ophthalmology. 2015. PMID: 25458197
Bevacizumab or Dexamethasone Implants for DME: 2-year Results (The BEVORDEX Study).
Fraser-Bell S, Lim LL, Campain A, Mehta H, Aroney C, Bryant J, Li J, Quin GJ, McAllister IL, Gillies MC. Fraser-Bell S, et al. Among authors: campain a. Ophthalmology. 2016 Jun;123(6):1399-401. doi: 10.1016/j.ophtha.2015.12.012. Epub 2016 Jan 9. Ophthalmology. 2016. PMID: 26783096 Free article. Clinical Trial. No abstract available.
Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration.
Barthelmes D, Campain A, Nguyen P, Arnold JJ, McAllister IL, Simpson JM, Hunyor AP, Guymer R, Essex RW, Morlet N, Gillies MC; Fight Retinal Blindness! Project Investigators. Barthelmes D, et al. Among authors: campain a. Br J Ophthalmol. 2016 Dec;100(12):1640-1645. doi: 10.1136/bjophthalmol-2015-308090. Epub 2016 Mar 18. Br J Ophthalmol. 2016. PMID: 26994110 Free PMC article.
46 results